Cargando...

Vaccination of biliary tract cancer patients with four peptides derived from cancer-testis antigens

In the context of a Phase I clinical trial, the long-term vaccination of advanced biliary tract cancer patients with peptides derived from four distinct cancer-testis antigens resulted in remarkable disease stability and in the elicitation of antigen-specific T-cell responses.

Gardado en:
Detalles Bibliográficos
Autor Principal: Aruga, Atsushi
Formato: Artigo
Idioma:Inglês
Publicado: Landes Bioscience 2013
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3782136/
https://ncbi.nlm.nih.gov/pubmed/24073370
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.24882
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!